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ABSTRACT
Background: Intestinal barrier disruption followed by bacterial translocation 
seems to play a role in secondary pancreatic infection in acute pancreatitis. The use of 
probiotics as a possible adjuvant strategy in the treatment of acute pancreatitis needs 
to be investigated.
Objective: The aim of this study was to determine the effects of dietary supple-
mentation with a prophylactically administered multispecies probiotic mixture on the 
markers of acute pancreatitis and on the occurrence of bacterial translocation.
Methods: Thirty adult male Wistar rats were randomly assigned to 1 of 3 groups 
of 10 rats each: (1) the PS group, in which the rats were given probiotic supplementation 
prior to induction of acute pancreatitis; (2) the WP group, in which the rats underwent 
surgery to induce acute pancreatitis without prior probiotic supplementation; and (3) the 
control group, in which the rats underwent sham surgery. For 14 days before surgery, 
animals in the PS group received a single daily dose containing ~1.2 × 109 colony-
forming units of a probiotic mixture administered intragastrically as a bolus. On day 15, 
the animals underwent surgery to induce acute pancreatitis (PS and WP groups) or 
simulated surgery (control group). Blood samples were collected to determine leukocyte 
count, amylase and lipase activities, and glucose and calcium concentrations immedi-
ately before and 6 and 12 hours after the beginning of the procedure. Samples of pan-
creas, spleen, liver, and mesenteric lymph nodes were harvested for microbiologic and 
histopathologic analysis after the last blood sample collection. The pathologist examin-
ing the histopathology was blinded to treatment assignment.
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Results: The mean leukocyte count was significantly increased in the PS group 
compared with the WP group (P = 0.018), whereas the serum amylase and lipase 
activities and the serum glucose and calcium concentrations were not significantly 
different between the 2 groups. Comparing the risk for tissue colonization in the PS 
group with that of the WP group, the odds ratio (OR) for pancreas was 2.91 (95% CI, 
0.13–67.10); liver, 66.55 (95% CI, 1.89–2282.66); spleen, 88.58 (95% CI, 3.04– 
2583.08); and mesenteric lymph nodes, 1.23 (95% CI, 0.06–25.48). When the risks 
for histopathologic changes were compared between the 2 groups, the OR for 
acinar necrosis was 1.73 (95% CI, 0.21–12.17); steatonecrosis, 12.08 (95% CI, 
1.26–115.54); hemorrhage, 1.38 (95% CI, 0.21–9.53); and leukocyte infiltration, 
5.91 (95% CI, 0.64–54.89).
Conclusion: Probiotic supplementation before the induction of acute pancrea-
titis was associated with a greater degree of bacterial translocation and pancreatic 
tissue damage in this animal model. (Curr Ther Res Clin Exp. 2009;70:136–148) 
© 2009 Excerpta Medica Inc.
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INTRODUCTION
Acute pancreatitis has a wide spectrum of severity and complications. Morbidity and 
mortality associated with acute pancreatitis are mainly due to multiple organ dysfunc-
tion that may occur in the severe form of the disease.1–3 Despite the large body of 
knowledge about the pancreas and associated diseases, treatment of acute pancreatitis 
continues to be a challenge.4–6
Pancreatic necrosis, considered the most severe local complication of acute pancreatitis, 
has been associated with an increased risk for mortality.7–10 The possibility of an associa-
tion between bacterial translocation and pancreatic necrosis in acute pancreatitis is being 
increasingly studied because the microorganisms associated with such secondary infection 
are gram-negative bacteria, such as those that colonize the gastrointestinal tract.11–16
Although some authors17–20 have defended the use of antibiotic therapy in pancre- 
atic infection, there is no consensus regarding its prophylactic use, even for the purpose 
of achieving selective decontamination of the bowel, because destabilization of the 
intestinal flora, alteration of the epithelial surface, and bacterial resistance may occur. 
A meta-analysis of 10 randomized controlled trials (RCTs) reported that the prophy-
lactic use of carbapenem versus other antibiotics in 1279 patients with acute necro-
tizing pancreatitis was not associated with preventive effects on pancreatic necrosis, 
reduced mortality rate, or efficacy in this clinical condition.21
Probiotics such as Lactobacillus plantarum 299 have been found to have advantages 
over antibiotics in the prevention of bacterial translocation.22 Probiotics produce 
antimicrobial factors and compete with pathogens for essential nutrients, preventing 
excessive pathogen growth without causing bacterial resistance.23 By mechanisms not 
yet completely understood, probiotics also seem to increase the production of secre-
tory immunoglobulin (Ig) A and prevent the proinflammatory activation of nuclear 
factor–κB, thereby modulating the inflammatory response.24–26 For example, Perdigon 
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et al27 found that Lactobacillus casei, Lactobacillus acidophilus, and yogurt enhanced the 
number of IgA-producing plasma cells in a dose-dependent manner.
Nonetheless, despite the encouraging results from studies of acute diarrhea treat-
ment, the effectiveness of probiotics remains dubious due to the discrepancy between 
the results obtained in humans and animals.28–32 Two meta-analyses of RCTs support 
the observation that probiotics, essentially Lactobacillus GG, significantly shorten the 
duration of acute infectious diarrhea by a mean of 18 hours (8 RCTs, 773 patients)28 
and 17 hours (7 RCTs, 675 patients).29 In a randomized, double-blind, placebo-
controlled study in 30 patients with Crohn’s disease, Chermesh et al30 found no sig-
nificant differences in prevention of postsurgical recurrence of Crohn’s disease between 
a probiotic treatment that contained a mixture of prebiotics and probiotics or placebo. 
Similarly, in an RCT in 129 patients scheduled to undergo major elective abdominal 
surgery,31 the rate of bacterial translocation, rate of gastric colonization, and incidence 
of postoperative septic morbidity were not significantly changed with the administra-
tion of L plantarum 299v. Some studies in animals had favorable findings with probi-
otics in preventing microbial translocation in experimental pancreatitis.28,32 However, 
the authors of a multicenter RCT trial in 298 patients with acute pancreatitis did not 
recommend prophylaxis with a combination of 6 strains of freeze-dried, viable bacte-
ria in a total daily dose of 1010 bacteria, plus cornstarch and maltodextrins.33 This 
controversy motivated the present study, in which dietary supplementation with a 
multispecies probiotic mixture in healthy animals was started before the experimental 
induction of acute pancreatitis to assess the effects of manipulating intestinal flora on 
the markers of acute pancreatitis and the preventive effects of bacterial translocation.
MATERIALS AND METHODS
This experimental study was approved by the Ethics Committee on Animal Research 
at the Biology Institute Roberto Alcântara Gomes, Rio de Janeiro State University, 
Rio de Janeiro, Brazil. All procedures followed the current guidelines for animal 
experimentation.34,35
Study Design
Thirty adult male Wistar rats weighing 300 to 350 g were randomly assigned to 
1 of 3 groups of 10 rats each: (1) the PS group, in which the rats were given probiotic 
supplementation prior to surgery to induce acute pancreatitis; (2) the WP group, in 
which the rats underwent surgery to induce acute pancreatitis without prior probiotic 
supplementation; and (3) the control group, in which the rats underwent sham sur-
gery. The animals were maintained at 23°C on a 12-hour light–dark cycle and allowed 
free access to water and standard laboratory chow for 14 days. Each day, the animals 
were weighed and their intake of water and chow was checked. During the 12 hours 
before the surgery, the animals were deprived of food but allowed access to water.
Probiotics
For 14 days before surgery, the PS group received a single daily dose of ~1.2 × 
109 colony-forming units (CFU) of a multispecies probiotic mixture consisting of 
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3 lactobacilli (Lactobacillus rhamnosus, L casei, and L acidophilus) and 1 bifidobacterium 
(Bifidobacterium longum). Doses were prepared in an aqueous solution (5 mL) and ad-
ministered intragastrically as a bolus with an orogastric catheter. Animals in the 
WP and control groups received 5 mL of water similarly administered once a day for 
14 days before surgery.
Surgical Procedures and Induction of Acute Pancreatitis
Acute pancreatitis was induced using the method described by Aho et al.36 On day 
15 of the experiment, after all of the animals underwent induction of general anesthe-
sia with inhalational halothane, the PS and WP groups underwent surgery to induce 
acute pancreatitis by inoculation of a 5% sodium taurocholate solution into the 
biliopancreatic duct (1 μL/kg body weight), and the control group underwent sham 
surgery. After cannulation of the duct, sodium taurocholate was administered by ret-
rograde injection at a rate of 1 μL/min under low and constant manual pressure. 
During the closure of the abdominal wall, 3 mL of 0.9% saline solution per 100 g of 
body weight was administered subcutaneously for fluid replacement. After recovery 
from anesthesia, the rats were allowed free access only to water.
Collection of Blood Samples
With rats under general anesthesia induced using inhalational halothane, blood 
samples were harvested for laboratory analysis using cardiac puncture immediately 
before (0 hour) and 6 and 12 hours after the beginning of the surgery. Laboratory 
analysis included determination of leukocyte count (laser/impedance measurement, 
Automated Hematological Counter KX-21N, Sysmex Corporation, Kobe, Japan) and 
concentrations of amylase (direct substrate, spectrophotometry, Biosystems, Inc., Foster 
City, California), lipase (6-metilresorufina, Roche Diagnostic Systems, Inc., Somerville, 
New Jersey), glucose (glucose oxidase/peroxidase, spectrophotometry, BioSystems), 
and calcium (spectrophotometry, Arzenazo III, BioSystems).
Microbiological Analysis
Twelve hours after surgery, mesenteric lymph nodes and fragments of pancreas, 
spleen, and liver were harvested under strict aseptic conditions and were processed for 
culture of aerobic microorganisms. At the end of the procedure, the animals were 
euthanized using an anesthetic overdose.
The samples were first cultured in brain–heart infusion broth (BHI, Oxoid Ltd., 
Basingstoke, United Kingdom) for 24 hours at 36°C. The samples in which bacterial 
growth occurred were cultured on blood agar (Oxoid Ltd.) for an additional 24 hours 
at 37°C. The Gram method was used to separate the microorganisms into distinct 
groups. Catalysis (using hydrogen peroxide) and coagulase (using rabbit’s coagulase 
plasma) tests were applied to the samples with gram-positive microorganisms for 
identification of Staphylococcus and Streptococcus strains. The following tests were ap-
plied to the samples with gram-negative microorganisms: Moeller decarboxylase 
broth with arginine (Becton, Dickinson SA, Le Pont de Claix, France) and OF glucose 
(Hugh-Leifson, Merck KGaA, Darmstadt, Germany) for fermentable and nonferment-
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able bacteria, respectively; and sulfide-indole-motility (Merck KGaA), double sugar 
(glucose and lactose) + urea,37 and Citrate Seg Simmons Agar (Merck, São Paulo, Brazil) 
for enterobacteriaceae.
Histopathologic Analysis
After being harvested, samples of the pancreas were fixed in 10% neutral buffered 
formalin, embedded in paraffin, sectioned at a thickness of 3 to 4 μm, and stained 
with hematoxylin and eosin. A pathologist who was blinded to the treatment assign-
ments assessed the slides under a light microscope. To determine the degree of acute 
pancreatitis, pancreatic damage was assessed using a 4-point scale that was based on 
the histologic features of acute pancreatitis (0 = no injury; 1 = mild injury; 2 = mod-
erate injury; and 3 = severe injury). The features assessed were the presence or absence 
of acinar necrosis, steatonecrosis, hemorrhage, and leukocyte infiltration.
Statistical Analysis
Block randomization was used to assign the animals to the 3 groups. The nonpara-
metric Kruskal-Wallis test (simultaneous comparison of the 3 groups) was used to test 
the null hypothesis of group similarity in relation to the conditions preceding the ex-
periment (body weight and water and food intake). A multiple linear regression model 
for repeated measures was used to assess the magnitude of the effect of supplementation 
with probiotics on the biochemical markers and leukocyte count immediately before 
(0 hour) and 6 and 12 hours after surgery. Multiple logistic regression analysis for 
repeated measurements was used to assess the independent contribution of probiotic use 
to bacterial growth in the pancreas, liver, spleen, and mesenteric lymph nodes, as well 
as the degree of pancreatic injury (acinar necrosis, steatonecrosis, hemorrhage, and 
leukocyte infiltration). P ≤ 0.05 was considered statistically significant. Statistical analyses 
were performed using Stata version 8.0 (StataCorp LP, College Station, Texas).
RESULTS
During the 14 days before the induction of acute pancreatitis, the groups did not 
behave uniformly regarding water or food consumption despite being housed in iden-
tical conditions. A significant difference between PS and WP groups was found in 
mean water intake (P = 0.010).
After the collection of the first blood sample on the day of acute pancreatitis induc-
tion, 2 animals died (1 each in the PS and control groups). Necropsy revealed blood 
clots in the pericardial sac, suggesting the occurrence of cardiac tamponade, possibly 
due to the cardiac puncture performed for blood collection. These 2 animals were 
excluded from the statistical analyses. All of the other animals recovered adequately 
from the surgical procedures and survived until the end of the experiment.
Six hours after the induction of acute pancreatitis the mean number of leukocytes 
was significantly increased in all 3 groups, with no significant reduction occurring at 
12 hours (Table I). The mean leukocyte count was significantly increased in the PS 
group compared with the WP group (P = 0.018). Starting at 6 hours after study drug 
administration, the mean serum activities of amylase and lipase were significantly 
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increased—to at least 3-fold that in animals without pancreatitis—in the PS and WP 
groups. The differences in serum amylase and lipase were not significant between PS 
and WP groups. Mean change in glycosylated hemoglobin concentrations were not 
significantly different between the PS and WP groups. Serum calcium concentrations 
were decreased progressively from baseline at 6 and 12 hours, but the between-group 
differences were not significant. 
No growth of aerobic bacteria was observed in any of the tissue samples from the 
control group. Twelve hours after the start of surgery to induce acute pancreatitis in 
the PS and WP groups, infection was found in the pancreas (5/9 vs 3/10 rats, respec-
tively), liver (6/9 vs 3/10 rats), spleen (4/9 vs 1/10 rats), and mesenteric lymph nodes 
(1/9 vs 1/10 rats) (Table II). On analysis of the risk for colonization of the tissues, 
probiotic supplementation did not protect the animals against greater colonization, 
especially in the pancreas (odds ratio [OR], 2.91; 95% CI, 0.13–67.10), liver (OR, 
66.55; 95% CI, 1.89–2282.66), and spleen (OR, 88.58; 95% CI, 3.04–2583.08) 
(Table II).
Intestinal bacteria were identified in the organ cultures in the PS and WP groups. 
Gram-negative bacteria (Escherichia coli, 7/36 vs 3/40 organ cultures, respectively; 
Pseudomonas aeruginosa, 11/36 vs 4/40 organ cultures) and gram-positive bacteria 
(Staphylococcus aureus, 0/36 vs 1/40 organ cultures) were identified.
On histopathologic examination of the pancreas, the following degenerative injuries 
were found in the PS and WP groups: acinar necrosis (median scores, 2.0 vs 1.8 points, 
respectively; OR, 1.73; 95% CI, 0.21–12.17), steatonecrosis (1.6 vs 0.9 points; OR, 
12.08; 95% CI, 1.26–115.54), hemorrhage (1.0 vs 0.8 points; OR, 1.38; 95% CI, 
0.21–9.53), and leukocyte infiltration (2.0 vs 1.6 points; OR, 5.91; 95% CI, 0.64–54.89) 
(Table III). No histologic changes were observed in the control animals.
A single histopathologic score was calculated by averaging the changes detected 
in the pancreatic tissue in the PS and WP groups (Table I). The use of probiotics 
Table I.  Effects of probiotic supplementation on leukocyte count, 
serum amylase and lipase activities, serum glucose and 
calcium concentrations, and histopathologic score 12 hours 
after the induction of acute pancreatitis in a rat model.
 PS (n = 9) vs  
Laboratory Finding WP (n = 10) P
Leukocyte count, 103 cells/mm3 2.58 0.018
Serum amylase, U/L –338.87 0.234
Serum lipase, U/L 11.76 0.805
Serum glucose, mg/dL 6.92 0.497
Serum calcium, mg/dL –0.04 0.801
Histopathologic score* 1.77 0.040
PS = probiotic supplementation; WP = without probiotic supplementation.
*Scale: 0 = no injury; 1 = mild injury; 2 = moderate injury; and 3 = severe injury.
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was not found to protect the animals from more severe injury: the difference in this 
score between the PS and WP groups was significant (P = 0.040). The risk for steato- 
necrotic histopathologic damage was greater in the PS group (OR = 12.08; 95% CI, 
1.26–115.54).
DISCUSSION
Probiotics are live microorganisms that, administered in sufficient amounts, have 
been associated with beneficial effects.38 Numerous studies have contributed to the 
understanding of probiotics.22,32,39,40 However, more information is needed regarding 
their effects in various clinical conditions.23
In the present study, supplementation with a multispecies probiotic mixture before 
the induction of acute pancreatitis in rats was not found to be beneficial. Inadequate 
Table II.  Intestinal bacterial colonization in extraintestinal tissues 12 hours after the 
induction of acute pancreatitis in a rat model.
Tissue PS WP Control Odds Ratio* 
Colonization (n = 9) (n = 10) (n = 9)  PS vs WP 95% CI
Pancreas 5/9 3/10 0/9 2.91 0.13–67.10
Liver 6/9 3/10 0/9 66.55 1.89–2282.66
Spleen 4/9 1/10 0/9 88.58 3.04–2583.08
Mesenteric lymph nodes 1/9 1/10 0/9 1.23 0.06–25.48
PS = probiotic supplementation; WP = without probiotic supplementation.
* Multiple logistic regression analysis for repeated measurements was used to assess the independent 
contribution of probiotic use to bacterial growth in the pancreas, liver, spleen, and mesenteric lymph 
nodes.
Number of Positive Cultures
Table III.  Histopathologic changes after the induction of acute pancreatitis in a rat 
model.
Histopathologic PS WP Odds Ratio† 
Change (n = 9) (n = 10) PS vs WP 95% CI
Acinar necrosis 2.0 1.8 1.73 0.21–12.17
Steatonecrosis 1.6 0.9 12.08 1.26–115.54
Hemorrhage 1.0 0.8 1.38 0.21–9.53
Leukocyte infiltration 2.0 1.6 5.91 0.64–54.89
PS = probiotic supplementation; WP = without probiotic supplementation.
*Scale: 0 = no injury; 1 = mild injury; 2 = moderate injury; and 3 = severe injury.
†    Multiple logistic regression analysis for repeated measurements was used to assess the independent 
contribution of probiotic use to the degree of pancreatic injury.
Median Score*
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doses or strains of probiotic bacteria or the time of administration may account for 
these findings. However, our findings did support those from several previously pub-
lished clinical studies30,31,41 and an experimental model.42 A prospective RCT by 
Woodcock et al41 found that the increase in IgA observed in the intestinal mucosa in 
response to probiotics in animal studies did not occur in humans after L plantarum 
299v supplementation. Bauer et al42 found that Lactobacillus GG (1–2 × 109 CFU/d 
for 8–10 days) did not prevent bacterial translocation and ascitic fluid infection in rats 
despite successful intestinal colonization.
Although probiotics are considered to be well tolerated,38 these live microorgan-
isms may be associated with adverse events (eg, infection, deleterious metabolic ac-
tivity, excessive immunologic stimulation, gene transfer to the endogenous flora) in 
susceptible individuals.23 Thus, this study used daily probiotic concentrations not 
exceeding 109 CFU per animal. This choice was supported by the significantly greater 
elevation in leukocyte count in the PS group compared with the WP group. 
Results from similar studies have been controversial.22,39 Van Minnen et al39 used 
a mixture of probiotics (L acidophilus, L casei, Lactobacillus salivarius, Lactococcus lactis, 
Bifidobacterium bifidum, and Bifidobacterium infantis) at a daily dosage of 5.0 × 
109 CFU/mL and observed a significant reduction in the supergrowth of pathogens 
(eg, E coli) in the duodenum; a reduction in bacterial translocation to distant organs, 
including the pancreas; improvement in the clinical course; and a reduction in late 
mortality. Mangiante et al22 obtained analogous findings in the occurrence of bacterial 
translocation after supplementation with L plantarum 299v when using a higher con-
centration of probiotics (5 mL/d of a suspension containing 0.5–1.0 × 109 CFU/mL). 
Nonetheless, PROPATRIA (Probiotic prophylaxis in predicted severe acute pancrea-
titis),33 an RCT in 298 patients with a diagnosis of severe acute pancreatitis, found 
that compared with placebo, prophylaxis with a combination of probiotics (L acidophilus, 
L casei, L salivarius, L lactis, B bifidum, and Bifidobacterium lactis) was not associat- 
ed with reductions in the risk for infectious complications (OR = 1.06; 95% CI, 
0.75–1.51) or in mortality (OR = 2.53; 95% CI, 1.22–5.25). A possible explanation 
for this negative result is that probiotic bacteria may have enhanced oxygen demand 
that was not supplied completely due to the presence of intestinal ischemia, which is 
common in such patients. Alternatively, the inflammatory response of the mucosa 
may have been caused by the presence of the probiotic bacteria themselves because gut 
epithelial cells under metabolic stress seem to react to commensal bacteria with an 
inflammatory response.43
Our negative findings might have been due to the strains of probiotic bacteria 
used. The strains were chosen based on studies of the effects of various probiotics on 
immune response and their ability to survive passage through the digestive tract.44–48 
We used a multispecies probiotic mixture because several studies recommended 
preparations with multiple strains, as no single strain possesses all of the desired prop-
erties.49,50 Some authors have reported that L rhamnosus, one of the strains used in our 
multispecies mixture, was isolated from 11 patients (12%) with Lactobacillus-induced 
bacteremia.51,52 However, L rhamnosus used in multispecies probiotic mixtures may be 
advantageous because Lactobacillus-induced bacteremia is a rare phenomenon that 
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mainly occurs when Lactobacillus is administered separately, especially in immunosup-
pressed patients.53
The present study had additional limitations. The probiotics were administered 
prophylactically for 14 days prior to the induction of acute pancreatitis. Although 
acute pancreatitis cannot be anticipated, it is a complication in 1% to 40% of patients 
who undergo endoscopic retrograde cholangiopancreatography (ERCP).54–56 Although 
preventing post-ERCP pancreatitis was not the aim of the present study, the prophy-
lactic administration of probiotic may be of value in such cases.
The ideal time for the institution of a prophylactic measure in acute pancreatitis 
has also been the subject of investigation. Two randomized, double-blind studies and 
one experimental study found that the initiation of probiotics or symbiotics after the 
onset of acute pancreatitis was effective.57,58 In the first clinical study, significant re-
ductions in the incidences of infectious complications and hospitalizations were found 
with L plantarum 299 used in 45 patients with pancreatitis.57 The same result, in the 
second clinical study, was found with the use of “Synbiotic 2000” (4 different lacto-
bacilli preparations with 1010 CFU, and prebiotics containing 4 bioactive fibers) in 
62 patients.58 The use of Streptococcus thermophilus, L acidophilus probiotics, and B lactis 
was found to significantly reduce the severity of acute pancreatitis in an experimental 
study.40 In 2 experimental studies in Lewis rats, probiotic supplementation with 
L plantarum (5 mL with 0.5 × 109 cells/mL during 4 days before and 4 days after the 
induction of pancreatitis),22,32 the authors recommended that supplementation be 
started as early as possible and continued after the onset of the signs and symptoms of 
acute pancreatitis.
Because bacterial translocation, which is potentially the cause of pancreatic infec-
tion and necrosis, often occurs in the early phases of acute pancreatitis,59 blood and 
tissue samples were collected within 12 hours after the induction of pancreatitis. The 
high rates of infection of extraintestinal organs, including the pancreas, found in the 
present study support the findings from previously published studies,60,61 suggesting 
that E coli, Fusobacterium spp, Proteus mirabilis, or Propionibacterium spp are the bacteria 
usually responsible for the contamination of pancreatic necrosis.60
The microbiologic study of pancreatic sepsis in humans is well characterized and 
reflects common gastrointestinal flora.62 The frequently isolated microorganisms include 
E coli, Pseudomonas spp, Proteus spp, Acinetobacter spp, Streptococcus spp, Staphylococcus spp, 
and Candida spp, among others. The strains of bacteria isolated in pancreatic necrosis 
may vary depending on the etiology of the acute pancreatitis. Gram-negative bacteria 
occur frequently in biliary pancreatitis, whereas gram-positive organisms are more 
common in alcoholic pancreatitis.63 Our findings were similar to those in infected 
pancreatic necrosis in humans, but we did not test for anaerobic bacteria or fungi. 
Several clinical studies have found that the prophylactic use of probiotics did not 
appear to be a promising alternative to the use of antibiotics.31,41,64 Two randomized 
clinical studies assessed the effects of the use of probiotics and symbiotics on the in-
cidences of bacterial translocation, gastric colonization, and septic complications in 
patients scheduled to undergo elective surgery.31,64 McNaught et al31 used L plantarum 
and Anderson et al64 used a symbiotic (oligofructose and a multispecies mixture of 
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probiotics) in 129 and 144 patients, respectively; both studies found that this prophy-
lactic use had no significant clinical benefit. Woodcock et al41 investigated the role of 
L plantarum in the function of gut-associated lymphoid tissue in 22 patients scheduled 
for elective surgery and found no significant increases in IgA or IgM concentrations 
in the intestinal mucosa, a finding that differs from usual findings in animals.65,66
Because of contradictory findings, we believe that further studies are needed using 
other strains of probiotic bacteria administered at various concentrations and at dif-
ferent times in relation to pancreatic injury to determine their role in bacterial trans-
location in rats.
CONCLUSION
In the present study, probiotic supplementation before the induction of acute pan-
creatitis was associated with a greater degree of bacterial translocation and pancreatic 
tissue damage in this animal model.
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